Technology
Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Source: TechCrunch · Published
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid…
Related stories
- CedarDB wants one database to handle both transactions and analytics, as AI agents raise the stakes
TechCrunch · 14 Oct 2026, 22:00
- Ambani’s Jio seeks to raise $3.2B in what could be India’s biggest IPO
TechCrunch · 14 Oct 2026, 21:48
- Flock CEO says its microphones detect ‘just gunshots’ — its website says different
TechCrunch · 14 Oct 2026, 21:30
- Colossal Biosciences announces new AI platform to help accelerate de-extinction efforts
TechCrunch · 14 Oct 2026, 21:00
- OpenAI accuses employee who left for Apple of leaking plans for unreleased device
The Guardian · 14 Oct 2026, 20:31
- Eight states accuse OpenAI of coaching children to harm themselves in lawsuit
The Guardian · 14 Oct 2026, 20:26
We are a news aggregator: we show the headline and a short excerpt with a link to the original source. We never republish full articles.
- #biosystems
- #drugmakers
- #intestines
- #intero
- #human
- #alternatives